Abortion Pill Reversal

I want to Reverse my Abortion*

I’ve already taken the first pill. Can I change my mind?

There is help available even after taking the abortion pill. It’s not unusual to have doubts after starting an abortion. You do not have to take the second pill or complete the abortion if you would like to stop the process. It is always your choice to change your mind.

How do I get help?

Even if you have started the chemical abortion process, reversal may still be a choice for you. To talk with someone about reversal, you can call 877-558-0333 or visit the Abortion Pill Reversal website. We're here for you! 

How does it work?

The first pill in a chemical abortion (mifepristone) lowers progesterone (a pregnancy hormone) and makes it difficult for the pregnancy to continue. A medical professional in the APR Network will prescribe progesterone to restabilize the pregnancy.

An ultrasound will be done as soon as possible to confirm heart rate, placement, and dating of your pregnancy. The treatment will usually continue for at least two weeks.

By giving extra progesterone in the abortion pill reversal protocol, the hope is to outnumber and outcompete the first abortion pill to reverse the effects. This increases the likelihood of continuing the pregnancy.

Is APR successful?

Initial studies of APR have shown it is successful about 68% of the time when oral progesterone is prescribed. APR has been shown to increase the chances of allowing the pregnancy to continue. However, the outcome of your particular reversal attempt cannot be guaranteed.

Is APR safe or will it cause birth defects?

Neither mifepristone nor progesterone is associated with birth defects.

The American College of Obstetricians and Gynecologists (ACOG) in its Practice Bulletin Number 225, October 2020, (reaffirmed in 2023) states that: “No evidence exists to date of a teratogenic effect of mifepristone.” There is no evidence that mifepristone, the first pill in the abortion pill regimen, causes any birth defects.

Progesterone has been safely used in pregnancy since the 1950s. Initial studies have found that the birth defect rate in babies born after APR is less than or equal to the rate in the general population.

Where do I start the APR protocol?

The APR Network is an international network with many medical professionals who are trained and ready to assist you with reversal. The hotline is staffed 24/7 and there is always a nurse ready to talk with you and provide the help you need. You can call the APR hotline at 877-558-0333 to speak with a nurse who will discuss the reversal process, answer your questions, and complete a medical intake with you. The nurse will then connect you with a medical professional in your area who is able to begin the reversal protocol. The nurse on the hotline will also be able to connect you with a local pregnancy center who can assist you with any additional needs or concerns you may have.

Where can I find more information about APR?

To learn more about APR you can visit the Abortion Pill Reversal website or call the APR hotline at 877-558-0333 to speak with a nurse about reversal. The APR website also has a Frequently Asked Questions page where you can read more about reversal. There is also a success stories page where you can read about other women’s experiences with APR. It is always your choice to change your mind and there is a network of caring staff ready to help you.


References

Abortion Pill Rescue. (2021, May). Progesterone protocols for the attempted reversal of mifepristone. https://aaplog.org/wp-content/uploads/2021/07/B-Progesterone-Protocols-05.2021-Final.pdf

Abortion Pill Reversal. (n.d.). Abortion pill reversal success stories. https://abortionpillreversal.com/abortion-pill-reversal/success-stories

Abortion Pill Reversal. (n.d.). Can the abortion pill be reversed?. https://abortionpillreversal.com/abortion-pill-reversal/overview

Abortion Pill Reversal. (n.d.). Contact us. https://abortionpillreversal.com/contact

Abortion Pill Reversal. (n.d.). Frequently asked questions. https://abortionpillreversal.com/abortion-pill-reversal/faq

Abortion Pill Reversal. (n.d.). https://abortionpillreversal.com/

American Association of Pro-Life Obstetricians and Gynecologists. (2020, February). Medication abortion. AAPLOG Practice Guideline, 8, 1-17. https://aaplog.org/wp-content/uploads/2023/01/PG-8-Medication-Abortion.pdf

American Association of Pro-Life Obstetricians and Gynecologists. (2022, November). The reversal of the effects of mifepristone by progesterone. AAPLOG Practice Guideline, 6, 1-5. https://aaplog.org/wp-content/uploads/2023/01/PG-6-Reversal-of-the-Effects-of-Mifepristone-by-Progesterone.pdf

American Association of Pro-Life Obstetricians and Gynecologists. (2019). 2019 AAPLOG position statement on abortion pill reversal. https://aaplog.org/wp-content/uploads/2019/02/2019-AAPLOG-Statement-on-Abortion-Pill-Reversal.pdf

Delgado, G., Condly, S. J., Davenport, M., Tinnakornsrisuphap, T., Mack, J., Khauv, V., & Zhou, P. S. (2018). A case series detailing the successful reversal of the effects of mifepristone using progesterone. Issues in Law & Medicine, 33(1), 21-31. https://pubmed.ncbi.nlm.nih.gov/30831017/

Drugs.com. (2023, March 3). Progesterone pregnancy and breastfeeding warnings. https://www.drugs.com/pregnancy/progesterone.html

NaProTechnology. (n.d.). Progesterone support in pregnancy. https://naprotechnology.com/progesterone/

Schreiber, C. A., Creinin, M. D., Atrio, J., Sonalkar, S., Ratcliffe, S. J., & Barnhart, K. T. (2018). Mifepristone pretreatment for the medical management of early pregnancy loss. The New England Journal of Medicine, 378, 2161-2170. 10.1056/NEJMoa1715726

The American College of Obstetricians and Gynecologists. (2020, October). Medication abortion up to 70 days of gestation. Practice Bulletin: Gynecology and the Society of Family Planning, 225. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/10/medication-abortion-up-to-70-days-of-gestation

 

Wallach, E. & Seegar Jones, G. (1976). The luteal phase defect. Fertility and Sterility, 27(4), 351-356. https://doi.org/10.1016/S0015-0282(16)41769-3